Ozempic Shows Early Anti-Aging Promise, but the Evidence Still Has Major Gaps Researchers Cannot Ignore
UC San Diego RCT found semaglutide slowed biological aging by 9%. But the study had 108 patients, all with HIV. Here is what the evidence shows and what it does not.
Read the full articleYou might also wanna read
Popular weight-loss drugs Ozempic and Wegovy may slow biological aging
Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking
Semaglutide slows epigenetic aging in a randomized trial of HIV-associated lipohypertrophy
Semaglutide slows epigenetic aging in HIV-associated lipohypertrophy. In a 32-week trial, 45 on semaglutide vs. 39 on placebo showed promisi
Clinical Trial Finds Ozempic Reverses Biological Age by 3.1 Years
- A randomized controlled trial of 108 people with HIV-associated lipohypertrophy found that weekly Ozempic treatment for 32 weeks reversed
GLP-1 drugs like Ozempic, Wegovy may help slow biological aging
Study Finds Ozempic Does Not Slow Alzheimer's Disease Progression
Novo Nordisk’s shares fell 6% on the news.

Ozempic maker backs game-changing GLP-1 implant to end drop-out
Novo Nordisk is evaluating a long-acting semaglutide implant designed to keep GLP-1 patients on treatment for months at a time – and food an

Ozempic maker backs game-changing GLP-1 implant to end drop-out
Novo Nordisk is evaluating a long-acting semaglutide implant designed to keep GLP-1 patients on treatment for months at a time – and food an

Comments
Sign in to join the conversation.
No comments yet. Be the first.